NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: thyssenkrupp nucera's 2024/2025 Financial Performance and Future Outlook
TL;DR
thyssenkrupp nucera achieved positive EBIT despite sales decline, positioning investors to benefit from their market leadership in green hydrogen technology during the energy transition.
thyssenkrupp nucera reported EUR 845 million in sales with EUR 2 million EBIT, showing improved performance in the Green Hydrogen segment despite challenging market conditions.
thyssenkrupp nucera's continued advancement in green hydrogen technology supports global climate goals by enabling cleaner energy solutions for a more sustainable future.
thyssenkrupp nucera successfully turned a EUR 14 million loss into a EUR 2 million profit while pioneering industrial-scale green hydrogen production technology.
Found this article helpful?
Share it with your network and spread the knowledge!
The company achieved sales of EUR 845 million (down from EUR 862 million in 2023/2024) and returned to profitability with EBIT of around EUR 2 million, compared to a loss of EUR -14 million in the previous year.
The gH2 segment achieved sales of EUR 459 million (down from EUR 524 million) but significantly improved its EBIT to EUR -56 million, compared to EUR -76 million in the previous year, showing progress toward profitability.
The CA segment saw double-digit sales growth to EUR 386 million (up from EUR 338 million) while EBIT was slightly lower at EUR 58 million compared to EUR 62 million in the previous year.
The company faces challenging market conditions for green hydrogen, including restraint in final investment decisions and a deteriorated global economic environment, leading to expected sales of EUR 500-600 million and EBIT of EUR -30 to 0 million.
Order intake declined to EUR 348 million (from EUR 636 million), with EUR 26 million from gH2 and EUR 322 million from CA segments, and the order backlog decreased to EUR 0.6 billion from EUR 1.1 billion the previous year.
thyssenkrupp nucera has initiated proactive measures to reduce the lower cost coverage associated with declining sales and minimize the impact on consolidated earnings, leveraging its strong market positioning and financial resilience.
Sales were slightly below the forecast range of EUR 850-920 million, while EBIT of EUR 2 million fell in the upper half of the forecast range of EUR -7 to 7 million.
The company generated positive free cash flow and continues to finance itself from its operating activities, indicating strong financial health despite market challenges.
Dr. Werner Ponikwar, CEO of thyssenkrupp nucera, is leading the company and expressed confidence in overcoming challenges through the company's excellent market positioning and financial resilience.
The return to profitability demonstrates the company's ability to navigate market challenges and improve operational efficiency, particularly notable given the difficult conditions in the green hydrogen market.
Curated from NewMediaWire
